A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.

Keywords

Chemokine, CCL5, Cancer research, Immunotherapy, T cell

References

• Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducersThomas J. Wolery, Norman H. Sleep — 1991
• CCR5 is characteristic of Th1 lymphocytesMatthias Vincenot — 1998
• Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.Rupert Negus, G. W. H. Stamp, J. Hadley — 1997
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.Giorgio Trinchieri — 1994
• IL-12 as Well as IL-2 Upregulates CCR5 Expression on T Cell Receptor-Triggered Human CD4+ and CD8+ T CellsYifu Yang, Michio Tomura, Masayuki Iwasaki — 2001
• Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.Charles S. Tannenbaum, Nicole B. Wicker, David A. Armstrong — 1996
• Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.Wengong Yu, Noriniko Yamamoto, Hiroshi Takenaka — 1996
• Molecular characterization of two murine eosinophil beta chemokine receptors.T W Post, C R Bozic, M.E. Rothenberg — 1995
• Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.J P Zou, Jun Shimizu, Kazuhiro Ikegame — 1992
• Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9.Landin Boring, Jennifa Gosling, Felipe S. Monteclaro — 1996
• Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.Stephen W. Russell, G. Yancey Gillespie, Ann Tozier McIntosh — 1977
• Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.Megumu Ogawa, Tateki Tsutsui, Jian-Ping Zou — 1997
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.Chet Nastala, Howard Edington, T G McKinney — 1994
• Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.Jie Mu, Jian‐Ping Zou, Norihiko Yamamoto — 1995
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.Marco Baggiolini, Béatrice Dewald, Bernhard Moser — 1994
• Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.Norio Yamamoto, J P Zou, X F Li — 1995
• Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitmentHermann‐Josef Gröne, Christian Weber, Kim S. C. Weber — 1999
• Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.Michio Tomura, Seiji Maruo, Jie Mu — 1998
• Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.Masako Murai, Hiroyuki Yoneyama, Akihisa Harada — 1999
• Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*)Amanda E. I. Proudfoot, Christine A. Power, Arlene J. Hoogewerf — 1996

Cited by

• Characterization of natural autoantibodies: A case for functional significanceParvathi Ranganathan — 2010
• Caractérisation moléculaire et fonctionnelle des lymphocytes T CD8+/CD103+ infiltrant les tumeurs pulmonaires humainesBrahim Fayçal Djenidi — 2014
• Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1Zhen Su, Jens Dannull, Benjamin Yang — 2005
• Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy 1Michael J. Gough, Marka R. Crittenden, Uma Thanarajasingam — 2005
• Induction of Tumor Regression by Administration of B7-Ig Fusion Proteins: Mediation by Type 2 CD8+ T Cells and Dependence on IL-4 Production1N. Yamaguchi, Shin-ichiro Hiraoka, Takao Mukai — 2004
• CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer PatientsFayçal Djenidi, Julien Adam, Aïcha Goubar — 2015
• IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production1Stefania Mitola, Marina Strasly, Mauro Prato — 2003
• Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic PlaqueXiaoyu Zhang, Alexander Niessner, Takako Eguchi Nakajima — 2006
• Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.Yuqing Liu — 2005
• CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinomaHsiu‐Ting Tsai, Shun-Fa Yang, Dar‐Ren Chen — 2012
• Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.Yuichi Takama, Shuji Miyagawa, Aki Yamamoto — 2011
• Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor.Yuji Saita, Mitsuhiro Kondo, Yasuaki Shimizu — 2007
• Reduced Expression of Chemokine Receptors on Peripheral Blood Lymphocytes in Patients with Hepatocellular CarcinomaYuqing Liu, Ronnie T.P. Poon, Xiaoqin Feng — 2004
• CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells.Souphalone Luangsay, Lloyd H. Kasper, Nicolas Rachinel — 2003
• Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.Naoko Kanagawa, Jianqing Gao, Yoshiaki Motomura — 2008
• Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse SarcomaAtanu Mallick, Subhasis Barik, Kuntal Kanti Goswami — 2013
• Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapyRajesh Sharma, Zinal Chheda, Venkatakrishna R. Jala — 2015
• Extracts from Citrus unshiu promote immune-mediated inhibition of tumor growth in a murine renal cell carcinoma model.Sang Gon Lee, Jehyeon Ra, Ju‐Young Song — 2011
• Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDSElwyn Gabutero, Corey Moore, S. Mallal — 2007
• Rituximab induces different but overlapping sets of genes in human B-lymphoma cell linesElena Cittera, Chiara Onofri, Maria D’Apolito — 2005

Related papers

• Chemokine receptor CCR5: from AIDS to atherosclerosisKL Jones, Janet J. Maguire, Anthony P. Davenport — 2011
• Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapyAudrey Lequeux, Muhammad Zaeem Noman, Malina Xiao — 2021
• Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapyMuhammad Zaeem Noman, Santiago Parpal, Kris Van Moer — 2020
• CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions.C Blattner, Viktor Fleming, Rebekka Weber — 2018
• Cancer associated fibroblast–derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axisHaixu Xu, Jie Zhao, Jin‐Ping Li — 2022
• The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.Polina Weitzenfeld, Adit Ben‐Baruch — 2014
• mRNA Delivery of a Bispecific Single Domain Antibody to Polarize Tumor-associated Macrophages and Synergize Immunotherapy Against Liver MalignanciesYing Wang, Karthik Tiruthani, Sirui Li — 2021
• Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin SignalingAnqi Luo, Min Meng, Guanying Wang — 2020
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor EradicationJoseph S. Durgin, David M. Weiner, Maria Wysocka — 2020